Cleadon Pharama Lists On Alternative Investments Market – First British Company To Join In 21 Years
Cannabis Law Report
APRIL 1, 2022
Its admission represents a ‘huge milestone for Celadon’, according to the new entity’s CEO James Short, but also for the UK cannabis industry at large. It also owns a majority stake in LVL Health , a chronic pain clinic, alongside a minority stake in cannabinoid-based biopharmaceutical company Kingdom Therapeutics. Admission
Let's personalize your content